{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:48:27Z","timestamp":1790866107882,"version":"4.1.0"},"reference-count":33,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2008,11,11]],"date-time":"2008-11-11T00:00:00Z","timestamp":1226361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology International"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:p>AKT plays an important role in malignant behavior of tumors. The purpose of the present study was to determine the expression of phosphorylated AKT (P\u2010AKT) and nuclear factor\u2010\u03baB (NF\u2010\u03baB) p65 and their association with clinicopathological parameters and prognosis in epithelial ovarian tumor. On immunohistochemistry 115 samples of ovarian tissue that included 68 specimens of epithelial ovarian cancer, 12 of borderline tumor, 24 of epithelial benign tumor and 11 of normal ovary, were evaluated. Sixty\u2010three patients with ovarian cancer were followed up from 7 to 68\u2003months. The positive expression rate of P\u2010AKT and NF\u2010\u03baB p65 were higher in epithelial ovarian cancer than in normal ovarian tissue (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). Elevated P\u2010AKT or NF\u2010\u03baB p65 expression was significantly correlated with late clinical stage (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05 and <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01) and poor histological differentiation (both <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). P\u2010AKT expression was significantly correlated with NF\u2010\u03baB p65 immunostaining (\u03c6\u2003=\u20030.272, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05). Elevated expression of P\u2010AKT was negatively correlated with the survival of ovarian cancer patients, but it was not an independent prognostic factor after multivariate analysis. Overexpression of P\u2010AKT and NF\u2010\u03baB p65 were involved in the carcinogenesis and metastasis of ovarian cancer. P\u2010AKT might contribute to the malignant transformation through NF\u2010\u03baBp65 upregulation.<\/jats:p>","DOI":"10.1111\/j.1440-1827.2008.02306.x","type":"journal-article","created":{"date-parts":[[2008,11,11]],"date-time":"2008-11-11T11:26:18Z","timestamp":1226402778000},"page":"749-756","source":"Crossref","is-referenced-by-count":54,"title":["Increased staining for phosphorylated AKT and nuclear factor\u2010\u03baB p65 and their relationship with prognosis in epithelial ovarian cancer"],"prefix":"10.1111","volume":"58","author":[{"given":"Rui\u2010Xia","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu\u2010Huan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu\u2010Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui\u2010Rong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui\u2010Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,11,11]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"854","article-title":"Mechanism of multidrug resistance of ovarian cancer","volume":"59","author":"Miedzinska\u2010maciejewska M","year":"2002","journal-title":"Przegl Lek"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207721"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208713"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207902"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-006-0410-7"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-858638"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-02-1441"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2005.06.051"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2005.11.013"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2005.10.003"},{"key":"e_1_2_6_12_2","first-page":"4236","article-title":"Nuclear factor\u2010kappaB p65(RelA)transcription factor is constitutively activated in human gastric carcinoma tissue","volume":"7","author":"Sasaki N","year":"2001","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.296.5573.1655"},{"key":"e_1_2_6_14_2","first-page":"1","article-title":"Adjustment of protein kinase B(PKB)\/Akt signaling pathway on cellular activity","volume":"1","author":"Guo RX","year":"2004","journal-title":"Chin Med e-J"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(02)00972-7"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2007.02186.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22195"},{"key":"e_1_2_6_18_2","first-page":"196","article-title":"Overexpression of Akt2 protein kinase Bbeta leads to up\u2010regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells","volume":"63","author":"Arboleda MJ","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.14.1.649"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-007-0396-5"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22315"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v10.i22.3255"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-006-9013-5"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2004.06.006"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025905008934"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2006.11.013"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209942"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1042\/BST0330346"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00422.2003"},{"key":"e_1_2_6_30_2","first-page":"5988","article-title":"Inhibition of BAD phosphorylation either at serine 112 via extracellular signal\u2010regulated protein kinase cascade or at serine 136 via AKT cascade sensitizes human ovarian cancer cells to cisplatin","volume":"60","author":"Hayakawa J","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M312044200"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402824"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0958"},{"key":"e_1_2_6_34_2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00029330-200602010-00014","article-title":"Blockage of PI3K\/PKB \/P27kip1 signaling pathway by LY294002 can antagonize Ishikawa proliferation and cell cycle progression induced by 17\u03b2\u2010estradiol","volume":"119","author":"Guo RX","year":"2006","journal-title":"Chin Med J"}],"container-title":["Pathology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1827.2008.02306.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1827.2008.02306.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T12:18:41Z","timestamp":1696940321000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1827.2008.02306.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,11]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1111\/j.1440-1827.2008.02306.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1827.2008.02306.x","archive":["Portico"],"relation":{},"ISSN":["1320-5463","1440-1827"],"issn-type":[{"value":"1320-5463","type":"print"},{"value":"1440-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,11]]}}}